DCM
ENZ

Dupont Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Dupont Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,710
Closed -$280K – 1003
2017
Q3 		$280K Sell
26,710
-36,306
-58% -$403K 0.01% 768
2017
Q2 		$696K Buy
+63,016
New +$587K 0.02% 604

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Dupont Capital Management's ENZ Position: Q4 2017 in Review

Dupont Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q4 2017, closing a stake of 26,710 shares — an estimated $280K sold.

Dupont Capital Management first reported a position in ENZ in Q2 2017 and held it in 2 quarters. The position peaked at $696K in Q2 2017. 115 funds tracked by Wall St. Rank hold ENZ as of Q4 2017.

  • Dupont Capital Management reported no remaining Enzo Biochem, Inc. position as of Q4 2017 after selling out during the quarter.
  • Dupont Capital Management sold 26,710 Enzo Biochem, Inc. shares in Q4 2017, an estimated $280K.
  • Dupont Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2017 and held it in 2 quarters.
  • Dupont Capital Management's Enzo Biochem, Inc. position peaked at $696K in Q2 2017.
  • 115 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2017.

Based on Dupont Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.